4//SEC Filing
Freeman Kevin Lee 4
Accession 0001562180-24-004989
CIK 0001636422other
Filed
Jun 11, 8:00 PM ET
Accepted
Jun 12, 4:25 PM ET
Size
5.1 KB
Accession
0001562180-24-004989
Insider Transaction Report
Form 4
Freeman Kevin Lee
Chief Commercial Officer
Transactions
- Sale
Common Stock
2024-06-11$6.53/sh−7,500$49,008→ 266,153 total
Footnotes (1)
- [F1]The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 11th, 2024 in accordance with Rule 10b5-1.
Documents
Issuer
Health Catalyst, Inc.
CIK 0001636422
Entity typeother
Related Parties
1- filerCIK 0001945797
Filing Metadata
- Form type
- 4
- Filed
- Jun 11, 8:00 PM ET
- Accepted
- Jun 12, 4:25 PM ET
- Size
- 5.1 KB